The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; MSD
Molecular therapy selection in treatment-refractory advanced cancers: A retrospective cohort study determining the utility of TOPOGRAPH knowledge base.
 
Frank Po-Yen Lin
No Relationships to Disclose
 
Subotheni Thavaneswaran
No Relationships to Disclose
 
John P. Grady
No Relationships to Disclose
 
Christine E Napier
No Relationships to Disclose
 
Maya Kansara
No Relationships to Disclose
 
Lucille Sebastian
Research Funding - AstraZeneca/MedImmune (Inst); Merck KGaA (Inst); Roche (Inst)
 
Damien Kee
No Relationships to Disclose
 
Samantha R. Oakes
No Relationships to Disclose
 
James Blackburn
No Relationships to Disclose
 
Hamish S. Scott
No Relationships to Disclose
 
Anthony Glover
No Relationships to Disclose
 
Stephen B. Fox
Consulting or Advisory Role - AstraZeneca (Inst); BMS (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - Amgen (Inst); AstraZeneca (Inst); BMS (Inst); Roche (Inst)
Expert Testimony - AstraZeneca (Inst); MSD (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD; Ventana Medical Systems
 
David Goldstein
Honoraria - Sun Biopharma
Consulting or Advisory Role - Seagen; sun biopharma
Research Funding - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); pfizer (Inst); Zucero Therapeutics (Inst)
 
Paul Leo
No Relationships to Disclose
 
Benhur Amanuel
No Relationships to Disclose
 
Jayesh Desai
Consulting or Advisory Role - Amgen (Inst); Bayer; BeiGene; Eisai; GlaxoSmithKline; Pierre Fabre
Research Funding - AstraZeneca/MedImmune (Inst); BeiGene (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis (Inst); Roche (Inst)
 
Chee Khoon Lee
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Merck KGaA; MSD Oncology; Novartis; Pfizer; Roche; Takeda; Yuhan
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Novartis; Takeda; Yuhan
Research Funding - AstraZeneca (Inst); Merck KGaA (Inst); Roche (Inst)
 
Mandy L. Ballinger
No Relationships to Disclose
 
John Simes
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
David Morgan Thomas
Honoraria - Bayer; Merck Sharp & Dohme; Merck Sharp & Dohme; Pfizer; Roche
Research Funding - Amgen; AstraZeneca; Bayer; Eisai; Elevation Oncology; IQvia; Pfizer; Roche
Travel, Accommodations, Expenses - Amgen